Debt to Equity
since 2005

Beginner level

Regeneron Pharmaceuticals Inc., debt to equity, long-term trends, calculation

	Debt to equity	=	Total debt¹	÷	Stockholders’ equity¹
Dec 31, 2020	0.24	=	2,695,700	÷	11,025,300
Dec 31, 2019	0.06	=	713,900	÷	11,089,700
Dec 31, 2018	0.08	=	708,500	÷	8,757,300
Dec 31, 2017	0.11	=	703,453	÷	6,144,078
Dec 31, 2016	0.11	=	481,126	÷	4,449,245
Dec 31, 2015	0.10	=	375,510	÷	3,654,837
Dec 31, 2014	0.18	=	459,064	÷	2,542,325
Dec 31, 2013	0.26	=	505,638	÷	1,952,076
Dec 31, 2012	0.37	=	458,637	÷	1,245,385
Dec 31, 2011	0.90	=	438,039	÷	485,732
Dec 31, 2010	0.31	=	162,859	÷	527,815
Dec 31, 2009	0.27	=	109,022	÷	396,762
Dec 31, 2008	0.00	=	—	÷	418,852
Dec 31, 2007	0.43	=	200,000	÷	460,267
Dec 31, 2006	0.92	=	200,000	÷	216,624
Dec 31, 2005	1.75	=	200,000	÷	114,002

¹ US$ in thousands

Regeneron Pharmaceuticals Inc., debt to equity, long-term trends, comparison to competitors

	Regeneron Pharmaceuticals Inc.	Abbott Laboratories	AbbVie Inc.	Amgen Inc.	Bristol-Myers Squibb Co.	Eli Lilly & Co.	Gilead Sciences Inc.	Illumina Inc.	Johnson & Johnson	Merck & Co. Inc.	Pfizer Inc.	Vertex Pharmaceuticals Inc.	Zoetis Inc.
Dec 31, 2020	0.24	0.57	6.58	3.51	1.34	2.94	1.73	0.25	0.56	1.26	0.63	0.07	1.91
Dec 31, 2019	0.06	0.58	—	3.09	0.91	5.88	1.09	0.25	0.47	1.02	0.83	0.09	2.38
Dec 31, 2018	0.08	0.64	—	2.71	0.52	1.30	1.28	0.53	0.51	0.94	0.66	0.13	2.95
Dec 31, 2017	0.11	0.90	7.33	1.40	0.68	1.18	1.64	0.49	0.57	0.71	0.60	0.29	2.80
Dec 31, 2016	0.11	1.07	7.95	1.16	0.41	0.74	1.39	0.58	0.39	0.62	0.71	0.71	3.00
Dec 31, 2015	0.10	0.42	8.03	1.12	0.47	0.55	1.20	0.60	0.28	0.59	0.60	0.86	4.56
Dec 31, 2014	0.18	0.36	8.62	1.19	0.53	0.52	0.80	0.88	0.27	0.44	0.51	0.75	2.78
Dec 31, 2013	0.26	0.26	3.28	1.45	0.55	0.30	0.58	0.57	0.25	0.50	0.48	0.36	3.89
Dec 31, 2012	0.37	0.77	4.66	1.39	0.54	0.37	0.88	0.64	0.25	0.39	0.46	0.68	0.14
Dec 31, 2011	0.90	0.63	—	1.13	0.34	0.52	1.13	0.75	0.34	0.32	0.47	0.58	—
Dec 31, 2010	0.31	0.85	—	0.56	0.35	0.56	0.59	0.26	0.30	0.33	0.50	1.07	—
Dec 31, 2009	0.27	0.72	—	0.47	0.43	0.70	0.18	0.34	0.29	0.30	0.54	0.14	—
Dec 31, 2008	0.00	0.65	—	0.50	0.55	1.55	0.31	0.47	0.28	0.33	0.30	1.20	—
Dec 31, 2007	0.43	0.69	—	0.63	0.59	0.37	0.38	0.97	0.22	0.32	0.20	0.07	—
Dec 31, 2006	0.92	0.88	—	0.48	0.74	0.34	0.77	0.00	0.17	0.39	0.11	0.24	—
Dec 31, 2005	1.75	0.46	—	0.19	0.77	0.60	0.10	0.00	0.07	0.45	0.27	0.75	—

Regeneron Pharmaceuticals Inc., debt to equity, long-term trends, comparison to sector (pharmaceuticals & biotechnology)

	Regeneron Pharmaceuticals Inc.	Pharmaceuticals & Biotechnology
Dec 31, 2020	0.24	1.20
Dec 31, 2019	0.06	1.12
Dec 31, 2018	0.08	1.00
Dec 31, 2017	0.11	0.93
Dec 31, 2016	0.11	0.84
Dec 31, 2015	0.10	0.70
Dec 31, 2014	0.18	0.57
Dec 31, 2013	0.26	0.53
Dec 31, 2012	0.37	0.55
Dec 31, 2011	0.90	0.49
Dec 31, 2010	0.31	0.45
Dec 31, 2009	0.27	0.44
Dec 31, 2008	0.00	0.42
Dec 31, 2007	0.43	0.34
Dec 31, 2006	0.92	0.30
Dec 31, 2005	1.75	0.30

Regeneron Pharmaceuticals Inc., debt to equity, long-term trends, comparison to industry (health care)

	Regeneron Pharmaceuticals Inc.	Health Care
Dec 31, 2020	0.24	0.92
Dec 31, 2019	0.06	0.91
Dec 31, 2018	0.08	0.83
Dec 31, 2017	0.11	0.84
Dec 31, 2016	0.11	0.79
Dec 31, 2015	0.10	0.71
Dec 31, 2014	0.18	0.55
Dec 31, 2013	0.26	0.51
Dec 31, 2012	0.37	0.53
Dec 31, 2011	0.90	0.47
Dec 31, 2010	0.31	0.43
Dec 31, 2009	0.27	0.42
Dec 31, 2008	0.00	0.41
Dec 31, 2007	0.43	0.36
Dec 31, 2006	0.92	0.33
Dec 31, 2005	1.75	0.31

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)